β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)
Clinical trial NCT01470989 · COMPLETED
Trial details
- NCT number
- NCT01470989
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-05-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.